Fasching PA, Decker T, Hartkopf A, Nusch A, et al. Efficacy, safety, and prognosis prediction in patients treated with ribociclib in combination with letrozole: Final results of phase 3b RIBECCA study in hormone receptor positive, human epidermal growth factor receptor-2 negative, locally advanced or Eur J Cancer 2023;198:113480.
PMID: 38154393